Correction: Rivastigmine modifies the α-secretase pathway and potentially early Alzheimer’s disease (Translational Psychiatry, (2020), 10, 1, (47), 10.1038/s41398-020-0709-x)

Balmiki Ray, Bryan Maloney, Kumar Sambamurti, Hanuma K. Karnati, Peter T. Nelson, Nigel H. Greig, Debomoy K. Lahiri

Research output: Contribution to journalComment/debate

Abstract

The original article contained few errors: Hanuma K. Karnati’s name was misstated in the author list, references 2 and 55 referred to the wrong sources, and the authors wanted to expand on their discussion of ChEIs on page 13. These errors have all been updated in the XML, PDF, and HTML versions of this article.

Original languageEnglish (US)
Article number81
JournalTranslational psychiatry
Volume10
Issue number1
DOIs
StatePublished - Dec 1 2020

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Cellular and Molecular Neuroscience
  • Biological Psychiatry

Fingerprint Dive into the research topics of 'Correction: Rivastigmine modifies the α-secretase pathway and potentially early Alzheimer’s disease (Translational Psychiatry, (2020), 10, 1, (47), 10.1038/s41398-020-0709-x)'. Together they form a unique fingerprint.

Cite this